{"schema_version":"1","generated_at":"2026-11-05T13:07:46.524Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/shyam-tanguturi","json_url":"https://www.findmykol.com/kol/shyam-tanguturi/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"shyam-tanguturi","name":"Shyam Tanguturi","credential":"MD","title":"Vice Chair of Network Strategy and Business Development for MGB Radiation Oncology","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology"],"institution":"Mass General Brigham","institution_url":"https://www.findmykol.com/institution/mass-general-brigham","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1992099956","orcid":"0000-0001-6479-1946","openalex":"A5003790985"},"summary":"Shyam Tanguturi is Vice Chair of Network Strategy and Business Development for MGB Radiation Oncology at Mass General Brigham. OpenAlex indexes 101 publications with 1,691 citations (h-index 20); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Shyam Tanguturi, M.D., is Vice Chair of Network Strategy and Business Development for MGB Radiation Oncology at Mass General Brigham. The public record shows 101 publications with 1,691 citations (h-index 20), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Management of metastatic bone disease. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies.","bullets":["Most recent indexed publication: 2026 · JNCI cancer spectrum","Top research focus: Glioma Diagnosis and Treatment","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 6 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Brain Metastases and Treatment","Management of metastatic bone disease","Advanced Radiotherapy Techniques","PARP inhibition in cancer therapy"],"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Viewray Technologies Inc","trials":0,"payments":4,"mentions":4},{"name":"IBA Proton Therapy, Inc.","trials":0,"payments":3,"mentions":3},{"name":"Mevion_Medical_Systems_Inc","trials":0,"payments":3,"mentions":3}]}},"scholarship":{"works_count":101,"cited_by_count":1691,"h_index":20,"i10_index":30,"pubmed_count":10,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT03557372","title":"Mathematical Model-Adapted Radiation In Glioblastoma","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT03557372","trial_url":"https://www.findmykol.com/trial/NCT03557372"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2022,"last":2025},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"IBA Proton Therapy, Inc.","program_year":2025,"amount_usd":500,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992099956"},{"payer":"SERVIER PHARMACEUTICALS LLC","program_year":2024,"amount_usd":2009.88,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992099956"},{"payer":"IBA Proton Therapy, Inc.","program_year":2024,"amount_usd":273,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992099956"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992099956","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Sensory organs","share_pct":52,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":52,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":48,"classes_total":1,"classes":[{"class":"N-methyl-D-aspartate Receptor Antagonist","setting":"prescribed","share_pct":48,"drugs":[{"name":"Memantine Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":7.9,"facility_pct":92.1},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":39,"years":{"first":2013,"last":2026},"societies":["ASCO","ASTRO","SNO"],"shown":3,"withheld":36,"rows":[{"title":"The Bermuda model: Achieving world-class, equitable, and efficient cancer care in a small island nation.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.11080","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.11080","status":"verified"},{"title":"Stereotactic radiation versus hippocampal avoidance whole brain radiation in patients with 5-20 brain metastases: A multicenter, phase 3 randomized trial.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.2011","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.2011","status":"verified"},{"title":"Feasibility of 3 Fraction Treatment Using Stereotactic Magnetic Resonance – Guided Adaptive Radiation Therapy in Single or Three Fractions for Oligometastases in the Abdomen and Pelvis: Results from the Phase I SMART-STOP 3-Fraction Cohort","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2025.06.2944","source_url":"https://doi.org/10.1016/j.ijrobp.2025.06.2944","status":"verified"}],"source":"congress"},"publications":{"total":10,"shown":5,"withheld":5,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Timing and prognosis of brain metastasis development in breast cancer by subtype.","year":2026,"journal":"JNCI cancer spectrum","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42776601/","status":"verified"},{"title":"Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: Implications for response assessment criteria.","year":2026,"journal":"Neuro-oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42108590/","status":"verified"},{"title":"Survival and treatment among older patients with brain metastases: a population-based study.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41912413/","status":"verified"},{"title":"Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Randomized Controlled Trial","Clinical Trial, Phase II"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42172567/","status":"verified"},{"title":"Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases.","year":2026,"journal":"Neurology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41747204/","status":"verified"}],"most_cited":{"total":101,"shown":5,"withheld":96,"rows":[{"title":"Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas","year":2016,"cited_by_count":263,"type":"article","source_url":"https://doi.org/10.1093/neuonc/now121"},{"title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","year":2010,"cited_by_count":211,"type":"article","source_url":"https://doi.org/10.1073/pnas.1006774107"},{"title":"An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome","year":2008,"cited_by_count":166,"type":"article","source_url":"https://doi.org/10.1371/journal.pmed.0050035"},{"title":"Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype","year":2017,"cited_by_count":134,"type":"article","source_url":"https://doi.org/10.1093/jnci/djx031"},{"title":"Outcomes of Proton Therapy for Patients With Functional Pituitary Adenomas","year":2014,"cited_by_count":124,"type":"article","source_url":"https://doi.org/10.1016/j.ijrobp.2014.06.068"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Patrick Yung Wen","coauthored_works":46},{"name":"Ayal Aaron Aizer","coauthored_works":42},{"name":"Rifaquat M. Rahman","coauthored_works":39}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/shyam-tanguturi-md","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Medical education: Harvard Medical School, 2011","source_url":"https://www.massgeneralbrigham.org/en/doctors/t/shyam-tanguturi-3004601","status":"verified","collected_at":"2026-11-04"},{"value":"Radiation Oncology, American Board of Radiology (board certification)","source_url":"https://www.massgeneralbrigham.org/en/doctors/t/shyam-tanguturi-3004601","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Dana-Farber Cancer Institute, Senior Physician","source_url":"https://www.dana-farber.org/find-a-doctor/shyam-k-tanguturi","status":"verified","collected_at":"2026-11-04"},{"value":"Harvard Medical School, Assistant Professor of Radiation Oncology (rank listed inconsistently across sources)","source_url":"https://www.dana-farber.org/find-a-doctor/shyam-k-tanguturi","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Areej El-Jawahri","slug":"areej-el-jawahri","institution":"Mass General Brigham","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/areej-el-jawahri","json_url":"https://www.findmykol.com/kol/areej-el-jawahri/profile.json"},{"name":"Rishi Singh","slug":"rishi-singh","institution":"Mass General Brigham","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/rishi-singh","json_url":"https://www.findmykol.com/kol/rishi-singh/profile.json"},{"name":"Tracey Simon","slug":"tracey-simon","institution":"Mass General Brigham","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/tracey-simon","json_url":"https://www.findmykol.com/kol/tracey-simon/profile.json"},{"name":"Zachariah Defilipp","slug":"zachariah-defilipp","institution":"Mass General Brigham","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/zachariah-defilipp","json_url":"https://www.findmykol.com/kol/zachariah-defilipp/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"David Reardon","slug":"david-reardon","institution":"Dana-Farber Cancer Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/david-reardon","json_url":"https://www.findmykol.com/kol/david-reardon/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"congress":36,"publications":5,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-11-04"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}